Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas van Bruggen

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Immunity|January 21, 2014
Th17 cells at the crossroads of autoimmunity, inflammation, and atherosclerosisNicholas van Bruggen, Wenjun Ouyang
Nature Reviews. Drug Discovery|July 2, 2008
Molecular imaging in drug developmentJürgen K Willmann, Nicholas van Bruggen, Ludger M Dinkelborg, et al.
Current Atherosclerosis Reports|May 3, 2013
Anti-inflammatory strategies for plaque stabilization after acute coronary syndromesAmos Baruch, Nicholas van Bruggen, Juyong Brian Kim, et al.
Drug Discovery Today. Technologies|July 4, 2014
New imaging paradigms in drug development: the PET imaging approachJan Marik, Sandra M Sanabria Bohorquez, Simon-Peter Williams, et al.
Magnetic Resonance in Medicine|July 29, 2010
Noncompartmental kinetic analysis of DCE-MRI data from malignant tumors: Application to glioblastoma treated with bevacizumabRuediger E Port, Lisa J Bernstein, Daniel P Barboriak, et al.
Plos One|July 23, 2013
Inhibition of VEGF-C modulates distal lymphatic remodeling and secondary metastasisAlvin Gogineni, Maresa Caunt, Ailey Crow, et al.
The Journal of Biological Chemistry|May 18, 2004
A novel in vivo role for osteoprotegerin ligand in activation of monocyte effector function and inflammatory responseDhaya Seshasayee, Hua Wang, Wyne P Lee, et al.
Journal of Magnetic Resonance Imaging : JMRI|September 30, 2008
Reactive hyperemia and BOLD MRI demonstrate that VEGF inhibition, age, and atherosclerosis adversely affect functional recovery in a murine model of peripheral artery diseaseJoan M Greve, Simon P Williams, Lisa J Bernstein, et al.
Magnetic Resonance in Medicine|March 9, 2004
Quantification of tumor tissue populations by multispectral analysisRichard A D Carano, Adrienne L Ross, Jed Ross, et al.
EJNMMI Research|June 2, 2012
FDG-PET is a good biomarker of both early response and acquired resistance in BRAFV600 mutant melanomas treated with vemurafenib and the MEK inhibitor GDC-0973Andreas R Baudy, Taner Dogan, Judith E Flores-Mercado, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Immunity|January 21, 2014
Th17 cells at the crossroads of autoimmunity, inflammation, and atherosclerosisNicholas van Bruggen, Wenjun Ouyang
Nature Reviews. Drug Discovery|July 2, 2008
Molecular imaging in drug developmentJürgen K Willmann, Nicholas van Bruggen, Ludger M Dinkelborg, et al.
Current Atherosclerosis Reports|May 3, 2013
Anti-inflammatory strategies for plaque stabilization after acute coronary syndromesAmos Baruch, Nicholas van Bruggen, Juyong Brian Kim, et al.
Drug Discovery Today. Technologies|July 4, 2014
New imaging paradigms in drug development: the PET imaging approachJan Marik, Sandra M Sanabria Bohorquez, Simon-Peter Williams, et al.
Magnetic Resonance in Medicine|July 29, 2010
Noncompartmental kinetic analysis of DCE-MRI data from malignant tumors: Application to glioblastoma treated with bevacizumabRuediger E Port, Lisa J Bernstein, Daniel P Barboriak, et al.
Plos One|July 23, 2013
Inhibition of VEGF-C modulates distal lymphatic remodeling and secondary metastasisAlvin Gogineni, Maresa Caunt, Ailey Crow, et al.
The Journal of Biological Chemistry|May 18, 2004
A novel in vivo role for osteoprotegerin ligand in activation of monocyte effector function and inflammatory responseDhaya Seshasayee, Hua Wang, Wyne P Lee, et al.
Journal of Magnetic Resonance Imaging : JMRI|September 30, 2008
Reactive hyperemia and BOLD MRI demonstrate that VEGF inhibition, age, and atherosclerosis adversely affect functional recovery in a murine model of peripheral artery diseaseJoan M Greve, Simon P Williams, Lisa J Bernstein, et al.
Magnetic Resonance in Medicine|March 9, 2004
Quantification of tumor tissue populations by multispectral analysisRichard A D Carano, Adrienne L Ross, Jed Ross, et al.
EJNMMI Research|June 2, 2012
FDG-PET is a good biomarker of both early response and acquired resistance in BRAFV600 mutant melanomas treated with vemurafenib and the MEK inhibitor GDC-0973Andreas R Baudy, Taner Dogan, Judith E Flores-Mercado, et al.
Pageof 3